Buscar
Mostrando ítems 101-110 de 551
Neoadjuvant Endocrine Therapy For Resectable Breast Cancer: A Systematic Review And Meta-analysis
(CHURCHILL LIVINGSTONEEDINBURGH, 2015)
Radioterapia de salvamento para cáncer de próstata y recaída bioquímica: cinco años de experiencia. Instituto Nacional de Cancerología
(Universidad del RosarioFacultad de medicina, 2011)
Patients with prostate cancer with tumors of low and intermediate risk of relapse can be treated with surgery, radiation therapy, and in selected cases observation. Patients in our country are treated with radical ...
Atividade antitumoral de inibidores de Histona Desacetilase como estratégia terapêutica contra o câncer cervical humano associado ao Papilomavírus Humano (HPV)
(Universidade Estadual Paulista (Unesp), 2021-12-16)
O câncer de colo de útero é o quarto tipo mais comum de câncer entre as mulheres. Sua principal causa é a infecção persistente pelo vírus Papilomavírus Humano (HPV) de alto risco, como o tipo 16 e o 18. As proteínas E6 e ...
Molecular Classification of breast cancerClasificación molecular del cáncer de mama
(Instituto de Cirugía de la Facultad de Medicina de la Universidad Austral de Chile y el Servicio de Cirugía del Hospital Clínico Regional de Valdivia, 2018)
Avaliação de receptores hormonais em mulheres com recorrência tardia de câncer de mama: estudo de caso controle
(Universidade Federal de Santa MariaBRMedicinaUFSMPrograma de Pós-Graduação em Ciências da Saúde, 2014-12-12)
The breast cancer, the second most common cancer in the world, is the most common among women, accounting for 25% of new cases of cancer each year. Statistics indicate an increase in global incidence. Important changes ...
Thymol as adjuvant in oncology: molecular mechanisms, therapeutic potentials, and prospects for integration in cancer management
(Springer Science and Business Media Deutschland GmbH, 2024)
Genetic and modifying factors that determine the risk of brain tumors
(2011-03-29)
Some modifying factors may determine the risk of brain tumors. Until now, it could not be attempted to identify people at risk and also to improve significantly disease progression. Current therapy consists of surgical ...
Genetic and modifying factors that determine the risk of brain tumors
(2011-03-29)
Some modifying factors may determine the risk of brain tumors. Until now, it could not be attempted to identify people at risk and also to improve significantly disease progression. Current therapy consists of surgical ...